Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.
Lanzon-Miller S. Aliment Pharmacol Ther. Jun 1987; 1(3): 239-51 Pubmed[5447]
Lao KS. CNS Drugs. Nov 2016; 30(11): 1043-1054 Pubmed[4905]
Larfors G. Eur J Haematol. Oct 2023; 111(4): 644-654 Pubmed[14323]
Lariam (Mefloquin). Roche Products Limited. Summary of product characteristics. August 2000 [904]
Larochelle P. Clin Pharmacol Ther. Jul 1979; 26(1): 24-30 Pubmed[2384]
Larsen JR. CNS Spectr. Aug 2019; 24(4): 441-452 Pubmed[14133]
Larsen JR. JAMA Psychiatry. Jul 2017; 74(7): 719-728 Pubmed[13943]
Larsen TR. Am J Case Rep. Jan 2014; 15: 45-8 Pubmed, Volltext, DOI[7336]
Larsen TR. Drug Saf Case Rep. Feb 2018; 5(1): 11 Pubmed[10874]
Larson KJ. J Clin Anesth. May 2015; 27(3): 247-51 Pubmed[3914]
Lasica M. Curr Hematol Malig Rep. Jun 2020; 15(3): 177-186 Pubmed[13932]
Lasswell WL et al. Drug Nutr Interact (1984) 2, 235-41 [1528]
Lasswell WL Jr. J Pharm Sci. Aug 1984; 73(8): 1056-8 Pubmed[2344]
Lasswell WL, Wilkins JM, Weber SS. In vitro interaction of selected drugs with coffee, tea, and gallotannic acid. Drug Nutr Interact (1984) 2, 235-41 [856]
Latham BD. Drug Metab Dispos. May 2025; 53(5): 100061 Pubmed[14296]
Lathia C. Cancer Chemother Pharmacol. Aug 2002; 50(2): 121-6 Pubmed[8183]
Lathia C. Cancer Chemother Pharmacol. May 2006; 57(5): 685-92 Pubmed[3742]
Lattanzi S. Neurol Ther. Sep 2022; 11(3): 1235-1252 Pubmed[13515]
Lau WC. Circulation. Jan 2003; 107(1): 32-7 Pubmed[3071]
Lau WC. Circulation. Jan 2004; 109(2): 166-71 Pubmed[3073]